Blog
RSS FeedPosted by Michael Wonder on 30 Mar 2023
Expanded access to subsidised oral antiviral Paxlovid and other COVID-19 supports
30 March 2023 - From 1 April, more than 160,000 people aged 60 to 69 will have access to the ...
Posted by Michael Wonder on 20 Feb 2023
Improve ventilation and make antiviral drug widely available, long COVID inquiry hears
20 February 2023 - GPs say they are unable to properly care for the hundreds of thousands of Australians with ...
Posted by Michael Wonder on 08 Feb 2023
All adults now eligible for a 2023 COVID-19 booster dose
8 February 2023 - The Australian Government has accepted advice from the Australian Technical Advisory Group on Immunisation that all adults ...
Posted by Michael Wonder on 19 Dec 2022
New report indicates COVID-19 vaccines saved Australia’s economy
19 December 2022 - Medicines Australia welcomes the latest peer-reviewed research paper indicating the rollout of the COVID-19 vaccinations significantly ...
Posted by Michael Wonder on 07 Dec 2022
Updated eligibility for COVID-19 oral treatment
7 December 2022 - COVID-19 treatments can be taken in your own home and can help reduce your symptoms. ...
Posted by Michael Wonder on 06 Dec 2022
Molnupiravir ‘effective Covid-19 anti-viral’: acting CMO Michael Kidd
6 December 2022 - Acting chief medical officer Michael Kidd has contradicted the nation’s top advisers on Covid-19 treatments on ...
Posted by Michael Wonder on 04 Dec 2022
Anti-viral drug should not be first choice in treating COVID-19
3 December 2022 - The most widely prescribed anti-viral drug in Australia, molnupiravir, should no longer be routinely given for ...
Posted by Michael Wonder on 24 Nov 2022
Outcome in relation to discussion of COVID-19 oral treatments – November 2022 PBAC meeting
24 November 2022 - A PBAC outcome in relation to discussion of COVID-19 oral treatments at the November 2022 meeting has ...
Posted by Michael Wonder on 17 Nov 2022
New COVID-19 vaccines for eligible Australians
15 November 2022 - The Australian Government has accepted a recommendation from the Australian Technical Advisory Group on Immunisation (ATAGI) on ...
Posted by Michael Wonder on 31 Oct 2022
Expanded access to COVID-19 oral antiviral treatments on the PBS
1 November 2022 - Expanded eligibility criteria for COVID-19 oral anti-viral treatments (Lagevrio (molnupiravir) and Paxlovid (nirmatrelvir and ritonavir) ...
Posted by Michael Wonder on 11 Oct 2022
Nearly a fifth of Australia’s Covid vaccine stock binned amid warning of fresh wave of cases
11 October 2022 - Dwindling demand for booster shots causes concern immunisation gaps leaving country open to new variants. ...
Posted by Michael Wonder on 10 Oct 2022
Australian adults can now get Moderna's Omicron COVID-19 booster. Here's what we know
10 November 2022 - The first combination COVID booster has now been introduced to Australia's vaccine program, with Moderna's Omicron ...
Posted by Michael Wonder on 22 Sep 2022
13 million Novavax doses due to expire as Australians stick to mRNA boosters
21 September 2022 - Novavax COVID vaccines procured by the federal government in the hopes of convincing hesitant Australians to ...
Posted by Michael Wonder on 12 Sep 2022
Australia's first bivalent COVID-19 vaccine to join rollout
12 September 2022 - The Australian Government has accepted a recommendation from the Australian Technical Advisory Group on Immunisation on the ...
Posted by Michael Wonder on 17 Aug 2022
Fears for patient safety with hundreds of medicines in short supply
17 August 2022 - Doctors and pharmacists are warning there could be serious consequences for patients if the shortage of hundreds ...